Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers

EP: 1.Alopecia Areata Clinical Presentation and Challenges in Treatment

EP: 2.Defining Alopecia Areata Severity and Navigating Treatment Options

EP: 3.Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata

Now Viewing

EP: 4.Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers

EP: 5.Options for Eyebrow and Eyelash Regrowth in a 32-Year-Old Female With Alopecia Areata

EP: 6.Laboratory Monitoring for JAK Inhibitors and Key Takeaways

Video content above is prompted by the following:

• Discuss the potential impact of untreated alopecia areata on a patient’s mental health, particularly in the adolescent patient population.
• What strategies can be used to address the psychosocial impact of alopecia areata in adolescents?

• How would you define the severity of this patient’s alopecia areata? How does the SALT score aid in determining severity and treatment approach?
• Describe your approach to pharmacologic treatment for this patient.
• What are your treatment goals, and how would you communicate these goals to the patient?
• What should this patient expect in terms of effectiveness with ritlecitinib? How would you discuss an expected timeline for hair regrowth with this patient and his family?
• What monitoring should be done before and during treatment with ritlecitinib?
• How would you discuss potential adverse effects of ritlecitinib with this patient? What should he and his family be aware of in terms of serious adverse events?
• Would you combine any other treatments (oral/topical minoxidil, oral/topical corticosteroids) with ritlecitinib?
• Discuss the importance of treatment adherence/persistence for ritlecitinib effectiveness. Will hair growth remain after treatment discontinuation?